Please take a few moments to read this fact sheet provided by Pfizer for healthcare providers administering the COVID-19 vaccine. I have included the most pertinent parts of the document below. You can click on the blue link below to read the entire document. I have also inserted my “cut to the chase” translations of the document for readers in red bold print.

(PLEASE EXCUSE THE FORMATTING ISSUES OBSERVED WITHIN THE LAYOUT OF THE PFIZER DOCUMENT ON THE NOFAKENEWS WEBSITE)

— Dr. John Reizer

FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE
(VACCINATION PROVIDERS) CLICK HERE TO READ FULL DOCUMENT!

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use
Authorization (EUA) to permit the emergency use of the unapproved product,
Pfizer-BioNTech COVID-19 Vaccine, for active immunization to prevent
COVID-19 in individuals 16 years of age and older.

(This means that this vaccine is an unapproved drug in the eyes of the FDA) – Dr. Reizer’s translation of the document.

The Pfizer-BioNTech COVID-19 Vaccine is a suspension for intramuscular injection
administered as a series of two doses (0.3 mL each) 3 weeks apart.

DESCRIPTION OF COVID-19

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
novel coronavirus, SARS-CoV-2, that appeared in late 2019. It is predominantly a
respiratory illness that can affect other organs. People with COVID-19 have
reported a wide range of symptoms, ranging from mild symptoms to severe illness.
Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may
include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches;
headache; new loss of taste or smell; sore throat; congestion or runny nose;
nausea or vomiting; diarrhea.

(The sars-cov-2 virus has never been isolated in totality from a human or animal host. The virus’s genetic signature was created using computer-modeling that input data taken from other known and previously isolated coronaviruses that have been around for decades. This virus has not been properly isolated or identified through the scientific methodologies known as Koch’s postulates.) -Dr. Reizer’s translation of the document.

Dosing and Schedule

The Pfizer-BioNTech COVID-19 Vaccine is administered intramuscularly as a
series of two doses (0.3 mL each) 3 weeks apart.

There are no data available on the interchangeability of the Pfizer-BioNTech
COVID-19 Vaccine with other COVID-19 vaccines to complete the vaccination
series. Individuals who have received one dose of Pfizer-BioNTech COVID-19
Vaccine should receive a second dose of Pfizer-BioNTech COVID-19 Vaccine to
complete the vaccination series.

Contraindications

Do not administer Pfizer-BioNTech COVID-19 Vaccine to individuals with known
history of a severe allergic reaction (e.g., anaphylaxis) to any component of the
Pfizer-BioNTech COVID-19 Vaccine (see Full EUA Prescribing Information).

(If you have a history of allergies, don’t take this product!) – Dr. Reizer’s translation of the document.

Warnings

Appropriate medical treatment used to manage immediate allergic reactions must
be immediately available if an acute anaphylactic reaction occurs
following administration of Pfizer-BioNTech COVID-19 Vaccine.

Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine.

(A significant portion of the US population has autoimmune disorders. If you don’t believe me, check out the number of pharmaceutical products advertised on mainstream media television stations every day designed to treat Lupus, Rheumatoid Arthritis, Chron’s disease, Addison’s disease, Psoriasis, Psoriatic arthritis, and I could go on and on. The point being, this vaccine won’t work for many people in the population, or said people may experience diminished immune responses to the vaccine according to the manufacturer’s own research.) Dr. Reizer’s translation of the document. 

Pfizer-BioNTech COVID-19 Vaccine may not protect all vaccine recipients.

Adverse Reactions

Adverse reactions following the Pfizer-BioNTech COVID-19 Vaccine reported in clinical trials include injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, malaise, and lymphadenopathy (see Full EUA Prescribing Information).

Severe allergic reactions have been reported following the Pfizer-BioNTech
COVID-19 Vaccine during mass vaccination outside of clinical trials.
Additional adverse reactions, some of which may be serious, may become
apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.

Serious adverse events are defined as:
• Death;
• A life-threatening adverse event;
• Inpatient hospitalization or prolongation of existing hospitalization;
• A persistent or significant incapacity or substantial disruption of the ability to
conduct normal life functions;
• A congenital anomaly/birth defect;

(Some adverse reactions/events have occurred in the rushed-through clinical trials. Additionally, severe allergic reactions have happened outside of the clinical trials, and more serious adverse reactions/events are expected with the more widespread use of the vaccine. Some of these reactions will probably include death!) – Dr. Reizer’s translation of the document.

AUTHORITY FOR ISSUANCE OF THE EUA

The Secretary of Health and Human Services (HHS) has declared a public health
emergency that justifies the emergency use of drugs and biological products during
the COVID-19 pandemic. In response, FDA has issued an EUA for the unapproved
product, Pfizer-BioNTech COVID-19 Vaccine, for active immunization against
COVID-19 in individuals 16 years of age and older.

The FDA issued this EUA, based on Pfizer-BioNTech’s request and submitted data.

(The Pfizer drug company asked the FDA for the emergency use of the non-approved product.) – Dr. Reizer’s translation of the document. 

The Countermeasures Injury Compensation Program

The Countermeasures Injury Compensation Program (CICP) is a federal program
that has been created to help pay for related costs of medical care and other
specific expenses to compensate people injured after use of certain medical
countermeasures. Medical countermeasures are specific vaccines, medications,
devices, or other items used to prevent, diagnose, or treat the public during a public health emergency or a security threat. For more information about CICP regarding the Pfizer-BioNTech COVID-19 Vaccine used to prevent COVID-19, visit
http://www.hrsa.gov/cicp, email cicp@hrsa.gov, or call: 1-855-266-2427.

(In other words, here’s some federal money that was set aside to take care of people who will be irreparably damaged from taking an unapproved drug product whose manufacturer has been granted complete liability immunity.) – Dr. Reizer’s translation of the document.